insights_auto
Why is RNAZ up 12.10%?
Dive Deeperchevron_right
RNAZ:NASDAQ
Transcode Therapeutics Inc
$1.76
arrow_upward
+12.10%(+0.19) 1D
$1.72
arrow_downward
-2.08% (-0.037)bedtimeAfter hours
Closed: Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RNAZ...
Open
$1.65
High
$1.87
Low
$1.57
Mkt. cap
29.80M
Avg. vol.
77.56K
Volume
0.00
52-wk high
$20.99
52-wk low
$1.52
EPS
-$50.76
Beta
1.25
Shares outstanding
16.93M
No. of employees
12
Open
$1.65
High
$1.87
Low
$1.57
Mkt. cap
29.80M
Avg. vol.
77.56K
Volume
0.00
52-wk high
$20.99
52-wk low
$1.52
EPS
-$50.76
Beta
1.25
Shares outstanding
16.93M
No. of employees
12
News stories
From web sources and news partners
Simply Wall Street
·
8 minutes ago
Manufacturing Approval Could Change The Case For Alvotech (ALVO) Stock
TradingView
·
1 hour ago
NYSE Owner Starts Gold Futures in London, a Market Without One Since 2022
MarketBeat
·
23 minutes ago
Community West Bancshares (NASDAQ:CWBC) Stock Has Consensus Price Target of $28.17
Seeking Alpha
·
1 hour ago
Cumberland's Monday Memo
About Transcode Therapeutics Inc
CEO-
Employees12
Founded2016
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitetranscodetherapeutics.com